Symbol
stringlengths 1
5
| Security
stringlengths 2
38
| GICS Sector
stringclasses 11
values | GICS Sub-Industry
stringlengths 4
55
| CIK
int64 1.8k
2.04M
| 2022_10q_q1
stringlengths 0
1.34M
| 2022_10q_q2
stringlengths 0
1.47M
| 2022_10q_q3
stringlengths 0
1.51M
| 2023_10q_q1
stringlengths 0
1.29M
| 2023_10q_q2
stringlengths 0
1.52M
| 2023_10q_q3
stringlengths 0
1.62M
| 2024_10q_q1
stringlengths 0
1.22M
| 2024_10q_q2
stringlengths 0
1.45M
| 2024_10q_q3
stringlengths 0
1.47M
| 2025_10q_q1
stringlengths 0
1.22M
| 2022_q1_10q_indexed_statements
listlengths 0
29
| 2022_q2_10q_indexed_statements
listlengths 0
35
| 2022_q3_10q_indexed_statements
listlengths 0
26
| 2023_q1_10q_indexed_statements
listlengths 0
26
| 2023_q2_10q_indexed_statements
listlengths 0
25
| 2023_q3_10q_indexed_statements
listlengths 0
29
| 2024_q1_10q_indexed_statements
listlengths 0
30
| 2024_q2_10q_indexed_statements
listlengths 0
32
| 2024_q3_10q_indexed_statements
listlengths 0
34
| 2025_q1_10q_indexed_statements
listlengths 0
31
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MMM
|
3M
|
Industrials
|
Industrial Conglomerates
| 66,740
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n\n#### (...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n\n#### (...TRUNCATED)
| "Table of Contents\n\n### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON(...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n\n#### (...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n\n#### (...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n\n#### (...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n\n#### (...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n\n#### (...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n\n#### (...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n\n#### (...TRUNCATED)
| [{"analysis":"This statement describes 3M's software license contracts and how revenue from these co(...TRUNCATED)
| [{"analysis":"Describes 3M's R&D investment activities, including specific areas of focus (applicati(...TRUNCATED)
| [{"analysis":"This statement directly refers to software license contracts, which falls under the 'S(...TRUNCATED)
| [{"analysis":"This statement directly reports on 3M's R&D spending as a percentage of sales, noting (...TRUNCATED)
| [{"analysis":"This statement directly indicates 3M has software license contracts as part of their b(...TRUNCATED)
| [{"analysis":"This statement directly references software license contracts, which falls under the c(...TRUNCATED)
| [{"analysis":"The statement directly identifies R&D as a priority for capital deployment, indicating(...TRUNCATED)
| [{"analysis":"This statement directly describes 3M's ongoing R&D investment activities, specifically(...TRUNCATED)
| [{"analysis":"This statement directly describes 3M's ongoing R&D investment activities and their foc(...TRUNCATED)
| [{"analysis":"This statement explicitly discusses 3M's ongoing investment in R&D activities across m(...TRUNCATED)
|
AOS
|
A. O. Smith
|
Industrials
|
Building Products
| 91,142
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n<div al(...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n<div al(...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n<div al(...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n<div al(...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n<div al(...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n<div al(...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n<div al(...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n<div al(...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n<div al(...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n<div al(...TRUNCATED)
|
[] |
[] |
[] |
[] |
[] |
[] | [{"analysis":"This statement directly indicates the company increased its R&D spending, which contri(...TRUNCATED)
|
[] |
[] |
[] |
ABT
|
Abbott Laboratories
|
Health Care
|
Health Care Equipment
| 1,800
| "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One)\n\n| (...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n\n#### (...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n\n#### (...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n\n#### (...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n\n#### (...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n\n#### (...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n\n#### (...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n\n#### (...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n\n#### (...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n\n#### (...TRUNCATED)
| [{"analysis":"Directly discusses Abbott's R&D spending increase in the first quarter of 2022, includ(...TRUNCATED)
| [{"analysis":"The statement directly reports an increase in the company's R&D expenses for Q2 2022, (...TRUNCATED)
| [{"analysis":"The statement describes impairment charges related to in-process R&D (IPR&D) assets wi(...TRUNCATED)
|
[] | [{"analysis":"The statement directly reports the company's R&D spending increase, quantifying R&D ef(...TRUNCATED)
| [{"analysis":"The statement describes Abbott accounting for $15 million in in-process research and d(...TRUNCATED)
| [{"analysis":"Directly refers to an in-process research and development asset, indicating ongoing R&(...TRUNCATED)
| [{"analysis":"Directly states R&D expense changes compared to prior year, clearly about research and(...TRUNCATED)
| [{"analysis":"This statement explicitly identifies in-process research and development (IPR&D) as a (...TRUNCATED)
| [{"analysis":"This statement provides a factual update on Abbott's R&D spending, noting an increase (...TRUNCATED)
|
ABBV
|
AbbVie
|
Health Care
|
Biotechnology
| 1,551,152
| "<div align='center'>UNITED STATES</div>\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTO(...TRUNCATED)
| "<div align='center'>UNITED STATES</div>\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTO(...TRUNCATED)
| "<div align='center'>UNITED STATES</div>\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTO(...TRUNCATED)
| "<div align='center'>UNITED STATES</div>\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTO(...TRUNCATED)
| "<div align='center'>UNITED STATES</div>\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTO(...TRUNCATED)
| "<div align='center'>UNITED STATES</div>\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTO(...TRUNCATED)
| "<div align='center'>UNITED STATES</div>\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTO(...TRUNCATED)
| "<div align='center'>UNITED STATES</div>\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTO(...TRUNCATED)
| "<div align='center'>UNITED STATES</div>\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTO(...TRUNCATED)
| "<div align='center'>UNITED STATES</div>\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTO(...TRUNCATED)
| [{"analysis":"AbbVie reports its share of development costs related to a collaboration with Genentec(...TRUNCATED)
| [{"analysis":"This statement directly describes AbbVie's reliance on ongoing research and developmen(...TRUNCATED)
| [{"analysis":"This statement directly reports AbbVie's research and development spending as part of (...TRUNCATED)
| [{"analysis":"Directly discusses R&D expenses related to acquired intellectual property and developm(...TRUNCATED)
| [{"analysis":"Describes evaluation of a drug candidate (ABBV-552) for development, directly related (...TRUNCATED)
| [{"analysis":"The statement describes AbbVie's shared research and development (R&D) activities and (...TRUNCATED)
| [{"analysis":"The company explicitly states ongoing evaluation of R&D operations for optimization op(...TRUNCATED)
| [{"analysis":"Directly states that research and innovation are fundamental to AbbVie's business mode(...TRUNCATED)
| [{"analysis":"This statement describes AbbVie's ongoing evaluation of its R&D operations to identify(...TRUNCATED)
| [{"analysis":"This statement describes a specific R&D activity (preclinical development) for a thera(...TRUNCATED)
|
ACN
|
Accenture
|
Information Technology
|
IT Consulting & Other Services
| 1,467,373
| "### UNITED STATES SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n\n#### FORM 10(...TRUNCATED)
| "### UNITED STATES SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n\n#### FORM 10(...TRUNCATED)
| "### UNITED STATES SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n\n#### FORM 10(...TRUNCATED)
| "### UNITED STATES SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n\n#### FORM 10(...TRUNCATED)
| "### UNITED STATES SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n\n#### FORM 10(...TRUNCATED)
| "### UNITED STATES SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n\n#### FORM 10(...TRUNCATED)
| "### UNITED STATES SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n\n#### FORM 10(...TRUNCATED)
| "### UNITED STATES SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n\n#### FORM 10(...TRUNCATED)
| "### UNITED STATES SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n\n#### FORM 10(...TRUNCATED)
| "### UNITED STATES SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n\n#### FORM 10(...TRUNCATED)
|
[] |
[] | [{"analysis":"This statement describes client demand for AI solutions as part of Accenture's managed(...TRUNCATED)
|
[] |
[] | [{"analysis":"This statement indicates client demand for AI as part of operations transformation, wh(...TRUNCATED)
| [{"analysis":"The statement indicates client demand for AI as part of their operational transformati(...TRUNCATED)
|
[] | [{"analysis":"This statement describes how Accenture's consulting revenue is directly driven by help(...TRUNCATED)
| [{"analysis":"This statement directly discusses Accenture's work with clients on implementing AI sol(...TRUNCATED)
|
ADBE
|
Adobe Inc.
|
Information Technology
|
Application Software
| 796,343
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n<div al(...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n<div al(...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n<div al(...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n<div al(...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n<div al(...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n<div al(...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n<div al(...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n<div al(...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n<div al(...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n<div al(...TRUNCATED)
| [{"analysis":"This statement describes AI features included in Adobe's Creative Cloud product as par(...TRUNCATED)
| [{"analysis":"This statement describes Adobe's integration of machine learning and artificial intell(...TRUNCATED)
| [{"analysis":"Describes Figma's product as a web-based design platform, which is a type of software.(...TRUNCATED)
| [{"analysis":"This statement directly discusses Adobe's investments in R&D, specifically mentioning (...TRUNCATED)
| [{"analysis":"This statement describes Adobe's software delivery model, specifically mentioning SaaS(...TRUNCATED)
| [{"analysis":"Adobe released Adobe Firefly, a group of creative generative AI models, after Septembe(...TRUNCATED)
| [{"analysis":"This statement describes Adobe's initiative to integrate AI into their products in a r(...TRUNCATED)
| [{"analysis":"Direct statement about Adobe's AI strategy to empower creators with responsible AI imp(...TRUNCATED)
| [{"analysis":"Describes Adobe's generative AI models for creative content creation.","context":"Crea(...TRUNCATED)
| [{"analysis":"This statement refers to Adobe's subscription revenue from its Digital Media and Digit(...TRUNCATED)
|
AMD
|
Advanced Micro Devices
|
Information Technology
|
Semiconductors
| 2,488
| "### UNITED STATES SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n\n#### FORM 10(...TRUNCATED)
| "### UNITED STATES SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n\n#### FORM 10(...TRUNCATED)
| "### UNITED STATES SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n\n#### FORM 10(...TRUNCATED)
| "### UNITED STATES SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n\n#### FORM 10(...TRUNCATED)
| "### UNITED STATES SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n\n#### FORM 10(...TRUNCATED)
| "### UNITED STATES SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n\n#### FORM 10(...TRUNCATED)
| "### UNITED STATES SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n\n#### FORM 10(...TRUNCATED)
| "### UNITED STATES SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n\n#### FORM 10(...TRUNCATED)
| "### UNITED STATES SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n\n#### FORM 10(...TRUNCATED)
| "### UNITED STATES SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n\n#### FORM 10(...TRUNCATED)
| [{"analysis":"This statement describes AMD's announcement of AI-focused technology including the Ins(...TRUNCATED)
| [{"analysis":"This statement directly describes AMD's acquisition of Pensando to enhance capabilitie(...TRUNCATED)
| [{"analysis":"This statement directly describes the company's in-process research and development ac(...TRUNCATED)
| [{"analysis":"This statement describes how AMD's acquisition of Pensando directly expands its comput(...TRUNCATED)
| [{"analysis":"This statement directly reports AMD's R&D expense increase, showing their investment i(...TRUNCATED)
| [{"analysis":"Directly states increased R&D investment in AI as a reason for decreased operating inc(...TRUNCATED)
| [{"analysis":"This statement identifies AI accelerators as a specific product category within AMD's (...TRUNCATED)
| [{"analysis":"Refers to the company's development and product offerings of hardware specifically des(...TRUNCATED)
| [{"analysis":"This statement indicates AMD's product portfolio includes AI Accelerators, which are h(...TRUNCATED)
| [{"analysis":"Refers to AMD's AI accelerator products within their Data Center segment.","context":"(...TRUNCATED)
|
AES
|
AES Corporation
|
Utilities
|
Independent Power Producers & Energy Traders
| 874,761
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n<div al(...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n<div al(...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n<div al(...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n<div al(...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n<div al(...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n<div al(...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n<div al(...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n<div al(...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n<div al(...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n<div al(...TRUNCATED)
| [{"analysis":"","context":"","statement":"","statement_match_indices":[-1,-1],"statement_match_simil(...TRUNCATED)
|
[] |
[] |
[] |
[] | [{"analysis":"Mentions investment in new technologies but is too vague to specifically relate to sof(...TRUNCATED)
|
[] |
[] |
[] | [{"analysis":"AES describes strategic investments in Uplight (energy management software) and Maximo(...TRUNCATED)
|
AFL
|
Aflac
|
Financials
|
Life & Health Insurance
| 4,977
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n\n#### (...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n\n#### (...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n\n#### (...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n\n#### (...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n\n#### (...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n\n#### (...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n\n#### (...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n\n#### (...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n\n#### (...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### Washington, D.C. 20549\n\n#### (...TRUNCATED)
| [{"analysis":"The statement describes modernizing a technology platform used for actuarial work, whi(...TRUNCATED)
| [{"analysis":"Describes Aflac Japan's use of a proprietary virtual sales tool for online insurance a(...TRUNCATED)
| [{"analysis":"Describes Aflac's efforts to modernize its actuarial technology platform, which involv(...TRUNCATED)
| [{"analysis":"This statement describes Aflac Japan's use of a proprietary virtual sales tool for onl(...TRUNCATED)
| [{"analysis":"Describes Aflac Japan's use of a proprietary virtual sales tool for online consultatio(...TRUNCATED)
| [{"analysis":"The statement describes Aflac Japan's use of a proprietary virtual sales tool for onli(...TRUNCATED)
| [{"analysis":"This statement describes Aflac Japan's use of proprietary software systems for digital(...TRUNCATED)
| [{"analysis":"This statement describes a third-party cloud hosting services agreement, directly rela(...TRUNCATED)
| [{"analysis":"This describes Aflac Japan's proprietary digital platform for insurance applications, (...TRUNCATED)
| [{"analysis":"Describes Aflac's proprietary system for smart device-based insurance applications, fi(...TRUNCATED)
|
A
|
Agilent Technologies
|
Health Care
|
Life Sciences Tools & Services
| 1,090,872
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n\n#### (...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n\n#### (...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n\n#### (...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n\n#### (...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n\n#### (...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n\n#### (...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n\n#### (...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n\n#### (...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n\n#### (...TRUNCATED)
| "### UNITED STATES\n\n### SECURITIES AND EXCHANGE COMMISSION\n\n#### WASHINGTON, D.C. 20549\n\n#### (...TRUNCATED)
| [{"analysis":"Directly states the company's R&D expense increase and reasons for it.","context":"Res(...TRUNCATED)
| [{"analysis":"This statement indicates Agilent's research and development expenses as part of their (...TRUNCATED)
| [{"analysis":"The company acquired advanced artificial intelligence technology, directly indicating (...TRUNCATED)
| [{"analysis":"This statement directly reports on the company's R&D expenses, showing a 5% increase c(...TRUNCATED)
| [{"analysis":"This describes a specific software product offered by Agilent in their Life Sciences a(...TRUNCATED)
| [{"analysis":"This describes specific software products offered by Agilent in their Life Sciences an(...TRUNCATED)
| [{"analysis":"This statement directly mentions research and development as an area of investment for(...TRUNCATED)
| [{"analysis":"This statement explicitly describes Agilent's specific software products for laborator(...TRUNCATED)
| [{"analysis":"Mentions software as a component of cell analysis business offerings, indicating its i(...TRUNCATED)
| [{"analysis":"This statement describes the company's strategic reorganization of its software and in(...TRUNCATED)
|
End of preview. Expand
in Data Studio
README.md exists but content is empty.
- Downloads last month
- 29